Type I Interferon: Understanding Its Role in HIV Pathogenesis and Therapy

Keyphrases

• Type I Interferon 100%
• HIV Treatment 100%
• IFN-I 100%
• HIV Pathogenesis 100%
• HIV Infection 66%
• Chronic Infection 66%
• Acute Infection 66%
• Plasmacytoid Dendritic Cells 66%
• IFN-I Signaling 66%
• Host Defense 33%
• Nonhuman Primate 33%
• HIV Life Cycle 33%
• HIV-1 Replication 33%
• Lymphoid Tissue 33%
• Natural Killer Cells 33%
• Mucosal Tissues 33%
• Cell Loss 33%
• CD4 T Cells 33%
• Combined Antiretroviral Therapy (cART) 33%
• Interventional Study 33%
• Restriction Factor 33%
• HIV Control 33%
• SIV Infection 33%
• Immune Exhaustion 33%
• HIV-I 33%

Medicine and Dentistry

• Human Immunodeficiency Virus 100%
• Interferon Type I 100%
• Infection 80%
• Human Immunodeficiency Virus Infection 40%
• Plasmacytoid Dendritic Cell 40%
• T-Helper Cell 20%
• Host Resistance 20%
• Antiretroviral Therapy 20%
• Natural Killer Cell 20%
• Immunity 20%
• Cell Loss 20%
• Life Cycle 20%
• Lymphoid Tissue 20%
• Mucosal Tissue 20%
• Simian Immunodeficiency Virus 20%

Immunology and Microbiology

• Human Immunodeficiency Virus 100%
• interferon 100%
• Human Immunodeficiency Virus Infection 40%
• Plasmacytoid Dendritic Cell 40%
• T-Helper Cell 20%
• Host Resistance 20%
• Life Cycle 20%
• Lymphoid Tissue 20%
• Mucosal Tissue 20%
• Natural Killer Cell 20%
• Immunity 20%
• Cell Loss 20%
• Simian Immunodeficiency Virus 20%